You are here: Industry Insights > HIV

News List

HIV treatment Dovato (dolutegravir/lamivudine) approved in Japan europeanpharmaceuticalreview
January 16, 2020
The Japanese Ministry of Health, Labour and Welfare (MHLW) has granted marketing approval for Dovato, a treatment for HIV-1 infection.
Single dose of antibodies can knock out HIV in newborns firstwordpharma
January 11, 2020
A single dose of an antibody-based treatment can prevent HIV transmission from mother to baby, new nonhuman primate research suggests for the first time.
Nurses Can Help Manage Drug Interactions in HIV/Hep C Treatment drugs
January 02, 2020
Drug interactions between antiretroviral therapy (ART) and direct-acting antivirals (DAAs) pose a clinical challenge in patients with HIV/hepatitis C virus (HCV) coinfection ...
GSK's long-acting HIV injectable hits FDA snag fiercepharma
December 27, 2019
HIV patients looking for relief from the burden of daily pills will have to wait a little longer.GlaxoSmithKline’s ViiV Healthcare said that the FDA had rejected its long-acting HIV injection ...
End-Stage Renal Disease Patients at Higher Risk for Syphilis drugs
December 26, 2019
End-stage renal disease (ESRD) patients are at a higher risk for contracting syphilis, according to a study recently published in the Clinical Kidney Journal.
Vyera licences HIV treatment from CytoDyn pharmaceutical-technology
December 23, 2019
Vyera Pharmaceuticals has entered agreements with CytoDyn to commercialise human immunodeficiency viruses (HIV) treatment leronlimab (PRO 140) in the US.
Antiretroviral Prescribing in Pregnancy Strays From National Guidelines drugs
December 20, 2019
For pregnant women with HIV, antiretroviral medication (ARV) prescribing practices do not align well with national guidelines, according to a study published online in JAMA Network Open.
ViiV Healthcare seeks approval for child-friendly HIV treatment pharmaceutical-technology
December 17, 2019
ViiV Healthcare has submitted applications seeking approval from US and European regulators for a 5mg dispersible-tablet (DT) formulation of its dolutegravir (DTG) drug to treat children with ...
J&J commits $500M investment to end TB, HIV biospectrumasia
October 08, 2019
As part of the $500 million investment, Janssen will continue to advance an investigational mosaic-based vaccine regimen to prevent HIV together with a consortium of partners.
Emergency Departments Need to Up HIV Testing, Linkage to Care drugs
September 24, 2019
HIV testing in South African emergency departments shows a high prevalence and incidence of HIV, as well as significant attrition along the HIV care cascade for HIV-positive individuals ...

Previous page 1 2 3 4 5 6 7 8 9 10 ... 24 25 Next page